The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
Kirsten K.T. Dirkx, Bert Mulder, Annelies Post, Martijn Rutten, C.M.A. Swanink, Heiman Wertheim, Amelieke J. H. Cremers
Abstract
OBJECTIVES: Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates. DESIGN: Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance. RESULTS: Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance. CONCLUSIONS: Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.